CDK2 inhibition enhances CDK4/6 inhibitor antitumor activity in comprehensive breast cancer PDX model screen. House NC, Chen MM, Khazaei S, Brown V, et al. NPJ Breast Cancer 2025;11:135.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

House NC, Chen MM, Khazaei S, Brown V, et al. CDK2 inhibition enhances CDK4/6 inhibitor antitumor activity in comprehensive breast cancer PDX model screen. NPJ Breast Cancer 2025;11:135.
PMID: 41339342